Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-26

Clinical Trial Update: Transgender Estradiol Affirming Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating transgender estradiol therapy for gender-affirming treatment has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL (Estradiol)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Transgenderism | Phase 2 | Status: COMPLETED | Results posted: 2024-11-26